Report on the risk assessment of N-(1‑phenethylpiperidin-4-yl)-N-phenylacrylamide (acryloylfentanyl) in the framework of the Council Decision on new psychoactive substances

Series type: Risk assessments

Summary

This publication presents the data and findings of the risk assessment on N-(1‑phenethylpiperidin-4-yl)-N-phenylacrylamide (acryloylfentanyl), carried out by the extended Scientific Committee of the EMCDDA on 22 February 2017. On the basis of the Risk Assessment Report — and on the initiative of the European Commission — on 25 September 2017, the Council decided that acryloylfentanyl should be subject to control measures across the Member States.

Download as PDF

Table of contents

  • Foreword
  • EMCDDA actions on monitoring and responding to new drugs
  • EMCDDA–Europol Joint Report on acryloylfentanyl: a summary
  • Risk Assessment Report of a new psychoactive substance: acryloylfentanyl
  • Annex 1: Technical report on acryloylfentanyl
  • Council Decision on subjecting acryloylfentanyl to control measures
  • Participants of the risk assessment meeting
Pages: 
50
Price: 
Free
ISBN: 
978-92-9497-238-5
ISSN: 
1725-4493
Pub. DOI: 
10.2810/252346
Catalog Number: 
TD-AK-17-001-EN-C
Loading